Stony Brook Heart Institute launches new program, offering minimally invasive therapies for symptomatic tricuspid valve ...

When a person has severe valve regurgitation, a surgeon may need to repair or replace the valves via open heart surgery. However, researchers have developed less invasive procedures and continue ...

The TEER procedure is highly recommended for patients who are considered high surgical risk due to pre-existing issues like ...

The aortic and pulmonic valves close preventing backward blood flow into the heart. The mitral and tricuspid valves then open to allow forward blood flow within the heart to fill the ventricles again.

Your heart also contains four valves that control blood flow through its chambers. Valvular regurgitation occurs when blood moves backward through one of these valves. The severity depends largely ...

The transcatheter heart valve replacement (TAVR) market is reported to reach a valuation of at USD 8.18 billion in 2025 to USD 32.82 billion by 2035. Demand for TAVR is expected to rise at a CAGR of ...

This successful TRIC valve implantation demonstrates the hospital’s commitment to cutting-edge cardiac care and underscores ...

Heart valve functions were defined by transoesophageal echocardiography before ... Long-term follow-up disclosed newly developed or worsened aortic valve regurgitation (AR) in 9% of patients with ASD ...

Inclusion criteria were as follows: (1) Study type: prospective clinical trials and retrospective cohort studies; (2) Diagnosis: patients diagnosed with aortic regurgitation (AR); (3) Intervention: ...

More than 1.6 million Americans have at least moderate to severe tricuspid regurgitation (TR), yet fewer than 8000 tricuspid valve (TV) operations are performed annually in the USA.1–3 The aetiology ...

The cardiology team at the MemorialCare Heart & Vascular Institute at Long Beach Medical Center, led by Chief of Cardiology David Shavelle, M.D., performed Long Beach Medical Center's first ...

In an era of continuous advancements in medical technology, Edwards Lifesciences (NYSE: EW), a global leader in ...